- AFB
acid-fast bacilli
- AIDS
acquired immunodeficiency syndrome
- ALA
alanine transaminase
- API
active pharmaceutical ingredients
- ART
antiretroviral therapy
- BCG
Bacillus Calmette–Guérin
- BMI
body mass index
- BMU
Basic Management Unit
- CBO
community-based organization
- CDC
United States Centers for Disease Control and Prevention
- CHW
community health worker
- CMV
cytomegalovirus
- CNS
central nervous system
- CPC
cetylpyridinum chloride
- CPT
cotrimoxazole preventive therapy
- CRI
colourimetric redox indicator
- CSO
civil society organization
- CU
compassionate use
- CYP3A4
cytochrome P450 3A4
- DOT
directly-observed therapy
- DOTS
core approach underpinning the Stop TB strategy for TB control
- DRS
drug resistance surveillance
- DST
drug susceptibility testing
- EA
expanded access
- EQA
external quality assessment
- ERP
Expert Review Panel
- FBO
faith-based organization
- FDC
fixed-dose combination
- FQ
fluoroquinolone
- FT4
free thyroxine
- GDF
Global Drug Facility
- GFR
glomerular filtration rate
- HIV
human immunodeficiency virus
- IHR
International Health Regulations
- IM
intramuscular
- ISTI
integrase strand transfer inhibitor
- LFT
liver function test
- LED
light emitting diode
- LPA
line probe assays
- MDR
multidrug resistance
- MDR-TB
multidrug-resistant tuberculosis
- MIC
minimum inhibitory concentration
- MODS
microscopic observation of drug susceptibility
- MOTT
mycobacteria other than tuberculosis
- MSH
Management Sciences for Health
- M/XDR-TB
multi- or extensively drug-resistant TB
- NCB
NGO coordinating body
- NGO
nongovernmental organization
- NRA
nitrate reductase assay
- NNRTI
non-nucleoside reverse transcriptase inhibitor
- NRTI
nucleoside reverse transcriptase inhibitor
- NTM
non-tuberculous mycobacteria
- NTP
national TB control programme
- PAS
p-aminosalicylic acid
- PCR
polymerase chain reaction
- PI
protease inhibitor
- PIH
Partners in Health
- PMDT
programmatic management of drug-resistant tuberculosis
- PPD
purified protein derivative
- PPM
public–private mix
- PQP
Prequalification of Medicines Programme
- rGLC
Regional Green Light Committee
- SGPT
serum glutamic-pyruvic transaminase
- QA
quality assurance
- QC
quality control
- QMS
quality management system
- QTcF
QT interval corrected for heart rate (Fridericia method)
- SCC
short-course chemotherapy
- SMX
sulfamethoxazole
- SOP
standard operating procedure
- SRA
Stringent Drug Regulatory Authority
- SRL
Supranational Reference Laboratory
- SSRI
selective serotonin re-uptake inhibitor
- TB
tuberculosis
- TB/HIV
HIV-related TB
- TMP
trimethroprim
- TSH
thyroid stimulating hormone
- UNAIDS
Joint United Nations Programme on HIV/AIDS
- UNION
International Union Against Tuberculosis and Lung Disease
- USAID
United States Agency for International Development
- UVGI
ultraviolet germicidal irradiation
- WHO
World Health Organization
- XDR-TB
extensively drug-resistant TB
